Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was a double-digit increase in service revenues.
Total revenues remained broadly unchanged at $2.06 million in the September quarter. An increase in service revenues was offset by a decline in product revenues.
Net loss attributable to Trxade Health was $3.53 million or $0.07 per share in the third quarter, compared to a loss of $0.53 million or $0.57 per share in the same period of last year.
Total registered users on the TRxADE platform increased by 870 or 6.17% compared to September 2022. For the nine months ended September 2023, new registrations were 196, compared to 296 for the same period in 2022. The company had a total of around 14,900+ registered members at the end of the quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
LLY Earnings: Eli Lilly Q4 2024 profit more than doubles; revenue up 45%
Eli Lilly and Company (NYSE: LLY) Thursday reported a sharp increase in its fourth-quarter revenues. The pharmaceutical company's adjusted earnings more than doubled during the quarter. Worldwide revenue increased 45%
Ford Motor Company (F) Earnings: 4Q24 Key Numbers
Ford Motor Company (NYSE: F) reported revenue of $48.2 billion for the fourth quarter of 2024, up 5% year-over-year. GAAP net income was $1.8 billion, or $0.45 per share, compared
Philip Morris (PM) Q4 2024 Earnings: Key financials and quarterly highlights
Philip Morris International Inc. (NYSE: PM) reported its fourth quarter 2024 earnings results today. Net revenues increased 7.3% year-over-year to $9.7 billion. Organic revenue growth was also 7.3%. Net loss attributable